FAQ
Log In
Tuesday 6th December 2016
News
 › 
 › 

Diabetes drug may increase bladder cancer risk

1st June 2012

A study based on NHS records has found that a drug used to control Type 2 diabetes could double the risk of bladder cancer.

Writing online in the British Medical Journal, the researchers from the Jewish General Hospital in Montreal, found that pioglitazone, which is taken by about 20,000 people and used to control blood sugar levels, increased the risk while the comparable drug rosiglitazone did not. Around 10,000 people are diagnosed with bladder cancer every year and almost 5,000 die of it.

 

Share this page

Comments

carol zhu

Thursday 14th June 2012 @ 20:41

According to another new study, it might also cause macular edema, which is the most common cause of blindness in adults


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2016